HRT

steelermom1

HRT

steelermom1

Prempro, a hormone replacement therapy (HRT) made by Wyeth Pharmaceutical, has been linked to a higher risk of breast cancer. In 2002, a major HRT study conducted by the National Institutes of Health (NIH) determined that Prempro and similar drugs significantly increased the risk of stroke, blood clots, heart attacks and breast cancer. In March 2008, the NIH released a follow up study that found that women who had ended combination HRT therapy still faced an increased risk of breast cancer. Women who took estrogen and progestin during the study but stopped in 2002 were still about 27 percent more likely to develop breast cancer than the women who did not take the hormones at all. More information on this vital topic can be found here:

http://www.yourlawyer.com/topics/overview/prempro